Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rouhollah Shabestan"'
Sotrovimab in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis
Publikováno v:
Korean Journal of Transplantation, Vol 37, Iss 4, Pp 277-285 (2023)
Background : Despite widespread implementation of vaccination against coronavirus disease 2019 (COVID-19), solid organ transplant recipients (SOTRs) can remain particularly vulnerable to this disease. The present study was conducted to investigate th
Externí odkaz:
https://doaj.org/article/08b893db07054e4dab4e3d3ae9194262
Publikováno v:
Journal of Pharmacoeconomics and Pharmaceutical Management, Vol 8, Iss 4 (2023)
Background: This study aims to compare combination therapy efficacy and safety with tamsulosin plus dutasteride versus tamsulosin in benign prostatic hyperplasia. Methods: An online search was conducted in PubMed, Cochrane Library, Embase, Scopus,
Externí odkaz:
https://doaj.org/article/88ef62395b9b4b4ba67bb68e5f8540b8
Autor:
Bahman Amani, Sara Zareei, Behnam Amani, Mahsa Zareei, Neda Zareei, Rouhollah Shabestan, Arash Akbarzadeh
Publikováno v:
Immunity, Inflammation and Disease, Vol 10, Iss 6, Pp n/a-n/a (2022)
Abstract Background and Objective Despite the pervasive vaccination program against coronavirus disease 2019 (COVID‐19), fully vaccinated people are still being infected by severe acute respiratory syndrome coronavirus 2, making an effective and sa
Externí odkaz:
https://doaj.org/article/0a54a962bcf6497586a267a7c0e3f258
Autor:
Nabi Shariatifar, Bahman Amani, Behnam Amani, Arash Akbarzadeh, Rouhollah Shabestan, Farhad Azadi
Publikováno v:
Health Technology Assessment in Action, Vol 2, Iss 1 (2019)
Background: Erectile dysfunction is a common disease that has a significant negative impact on the quality of life of individuals. Low-intensity shockwave therapy (LI-ESWT) has been considered a new method for treating patients with erectile dysfunct
Externí odkaz:
https://doaj.org/article/14b66489f0ce4bcfa567e87d3c780b43
SARS-CoV-2 breakthrough infection and death in COVID-19 vaccines recipients in North of Iran in 2021
Autor:
Rouhollah Shabestan, Bahman Amani, Behnam Amani, Arash Akbarzadeh, Maryam Zamani, Mohammad Saeidi, Seyede Roghayyeh Mirshojaie, Narjes Abdolmohammadi, Mohammad Reza Parsaie, Korosh Rajabkhah, Vida Kardanmoghadam, Seyede Samaneh Momeni
Aim: This study aimed to assess the cases of SARS-CoV-2 breakthrough infection and death among AZD1222, Sinopharm, Sputink V, Soberana, and COVAXIN vaccines receivers in Mazandaran. Methods: This retrospective cohort study was involving 320260 cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e674a889b2f03a58be46fec7161e3176
https://doi.org/10.22541/au.166072142.27735652/v1
https://doi.org/10.22541/au.166072142.27735652/v1
